Interchange Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Sell |
984
-177
| -15% | -$71.8K | 0.09% | 175 |
|
|
2025
Q1 | $578K | Buy |
1,161
+9
| +0.8% | +$4.48K | 0.16% | 122 |
|
|
2024
Q4 | $603K | Sell |
1,152
-393
| -25% | -$206K | 0.22% | 115 |
|
|
2024
Q3 | $957K | Sell |
1,545
-26
| -2% | -$16.1K | 0.34% | 78 |
|
|
2024
Q2 | $869K | Buy |
1,571
+835
| +113% | +$462K | 0.32% | 83 |
|
|
2024
Q1 | $431K | Buy |
736
+21
| +3% | +$12.3K | 0.29% | 84 |
|
|
2023
Q4 | $380K | Sell |
715
-108
| -13% | -$57.5K | 0.29% | 87 |
|
|
2023
Q3 | $417K | Buy |
823
+144
| +21% | +$72.9K | 0.33% | 77 |
|
|
2023
Q2 | $355K | Sell |
679
-404
| -37% | -$211K | 0.27% | 93 |
|
|
2023
Q1 | $627K | Buy |
1,083
+636
| +142% | +$368K | 0.34% | 73 |
|
|
2022
Q4 | $246K | Buy |
447
+1
| +0.2% | +$551 | 0.25% | 96 |
|
|
2022
Q3 | $226K | Sell |
446
-35
| -7% | -$17.7K | 0.25% | 126 |
|
|
2022
Q2 | $261K | Sell |
481
-9
| -2% | -$4.88K | 0.29% | 106 |
|
|
2022
Q1 | $289K | Buy |
+490
| New | +$289K | 0.3% | 111 |
|
|
2021
Q4 | – | Sell |
-756
| Closed | -$431K | – | 191 |
|
|
2021
Q3 | $431K | Sell |
756
-2
| -0.3% | -$1.14K | 0.72% | 51 |
|
|
2021
Q2 | $382K | Sell |
758
-72
| -9% | -$36.3K | 0.59% | 62 |
|
|
2021
Q1 | $393K | Sell |
830
-31
| -4% | -$14.7K | 0.21% | 146 |
|
|
2020
Q4 | $401K | Buy |
+861
| New | +$401K | 0.22% | 126 |
|